Labelone is a leading converter primarily focused on the healthcare industry in Northern Ireland. Sales for the annualized period ending March 31, 2016, were approximately $10.7 million, with an adjusted estimated EBITDA of $3.0 million. Purchase price consideration, including assumed debt, is approximately $17.7 million.
Guenther Birkner, president-Food & Beverage/Healthcare & Specialty Worldwide, and CCL top executive in Europe, says, "We are pleased to welcome Labelone's MD Michael McGarry and his team to CCL. Michael has deep industry experience and knowledge of the Irish label market and will take over management of our Dublin operation to maximize opportunities in an important country for our Healthcare business in Europe. Labelone will change its trading identity to CCL Label, effective immediately post-closing."
Geoffrey T. Martin, president/CEO of CCL Industries, adds, "A number of us at CCL Label have known Michael and his company for many years and we are fortunate to have Labelone join our important healthcare franchise."